Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentpostsynaptic cytoskeleton

MYO5B MYO6 SPTBN2 CTTN

1.45e-0626684GO:0099571
GeneOntologyCellularComponentpostsynaptic actin cytoskeleton

MYO5B MYO6 CTTN

3.07e-0519683GO:0098871
GeneOntologyCellularComponentNatA complex

NAA15 NAA16

1.04e-045682GO:0031415
GeneOntologyCellularComponentN-terminal protein acetyltransferase complex

NAA15 NAA16

4.61e-0410682GO:0031414
DomainCmyb_C

MYB MYBL1 MYBL2

4.62e-083683PF09316
DomainC-myb_C

MYB MYBL1 MYBL2

4.62e-083683IPR015395
DomainHTH_MYB

MYB MYBL1 MYBL2

3.82e-069683PS51294
DomainMyb_dom

MYB MYBL1 MYBL2

3.82e-069683IPR017930
DomainNatA_aux_su

NAA15 NAA16

1.31e-052682IPR021183
DomainTscrpt_reg_Wos2-domain

MYB MYBL1

1.31e-052682IPR012642
DomainNARP1

NAA15 NAA16

1.31e-052682PF12569
DomainLMSTEN

MYB MYBL1

1.31e-052682PF07988
DomainMyb_DNA-binding

MYB MYBL1 MYBL2

2.78e-0435683PF00249
DomainMYB_LIKE

MYB MYBL1 MYBL2

3.55e-0438683PS50090
DomainSANT

MYB MYBL1 MYBL2

8.00e-0450683SM00717
DomainSANT/Myb

MYB MYBL1 MYBL2

8.98e-0452683IPR001005
Domain-

RLF ZFP3 ZNF814 ZNF75D ZBTB26 ZNF418 ZNF587B ZNF585B

3.16e-036796883.30.160.60
Domainzf-C2H2

RLF ZFP3 ZNF814 ZNF75D ZBTB26 ZNF418 ZNF587B ZNF585B

3.58e-03693688PF00096
DomainZnf_C2H2/integrase_DNA-bd

RLF ZFP3 ZNF814 ZNF75D ZBTB26 ZNF418 ZNF587B ZNF585B

3.61e-03694688IPR013087
DomainSR

CORIN CD163

3.71e-0325682SM00202
DomainSRCR_1

CORIN CD163

4.01e-0326682PS00420
DomainSRCR_2

CORIN CD163

4.01e-0326682PS50287
DomainSRCR-like_dom

CORIN CD163

4.01e-0326682IPR017448
DomainSRCR

CORIN CD163

4.32e-0327682IPR001190
Domain-

NELL2 LMAN2L WDFY3

5.03e-03956832.60.120.200
DomainZINC_FINGER_C2H2_2

RLF ZFP3 ZNF814 ZNF75D ZBTB26 ZNF418 ZNF587B ZNF585B

6.96e-03775688PS50157
DomainZINC_FINGER_C2H2_1

RLF ZFP3 ZNF814 ZNF75D ZBTB26 ZNF418 ZNF587B ZNF585B

7.06e-03777688PS00028
Pubmed

The myb gene family in cell growth, differentiation and apoptosis.

MYB MYBL1 MYBL2

7.81e-09370310378697
Pubmed

Temporal patterns of A-myb and B-myb gene expression during testis development.

MYB MYBL1 MYBL2

3.12e-0847038808690
Pubmed

The Wnt-NLK signaling pathway inhibits A-Myb activity by inhibiting the association with coactivator CBP and methylating histone H3.

MYB MYBL1 MYBL2

1.55e-07670316055500
Pubmed

Tubedown associates with cortactin and controls permeability of retinal endothelial cells to albumin.

NAA15 CTTN

3.99e-06270218495841
Pubmed

Cloning and characterization of myr 6, an unconventional myosin of the dilute/myosin-V family.

MYO5B MYO6

3.99e-0627028855265
Pubmed

Pediatric-type diffuse low-grade glioma with MYB/MYBL1 alteration: report of 2 cases.

MYB MYBL1

3.99e-06270236074655
Pubmed

MYB and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts.

MYB MYBL1

3.99e-06270229410490
Pubmed

DNA binding and transactivation activity of A-myb, a c-myb-related gene.

MYB MYBL1

3.99e-0627027987850
Pubmed

Adenoid cystic carcinoma of the Bartholin's gland is underpinned by MYB- and MYBL1- rearrangements.

MYB MYBL1

3.99e-06270238368814
Pubmed

Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course.

MYB MYBL1

3.99e-06270231563982
Pubmed

Activation of the G-CSF and Flt-3 receptors protects hematopoietic stem cells from lethal irradiation.

FLT3 CSF3R

3.99e-06270214585378
Pubmed

Characterization and cell cycle-regulated expression of mouse B-myb.

MYB MYBL2

3.99e-0627021501895
Pubmed

Expression of mouse c-myb during embryonic development.

MYB MYBL1

3.99e-0627028570177
Pubmed

Arrest of spermatogenesis and defective breast development in mice lacking A-myb.

MYB MYBL1

3.99e-0627029109487
Pubmed

Expression of B-Myb during mouse embryogenesis.

MYB MYBL2

3.99e-0627028649849
Pubmed

A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration.

MYB MYBL1

3.99e-06270231595312
Pubmed

Isolation of human cDNA clones of myb-related genes, A-myb and B-myb.

MYBL1 MYBL2

3.99e-0627023060855
Pubmed

Detecting MYB and MYBL1 fusion genes in tracheobronchial adenoid cystic carcinoma by targeted RNA-sequencing.

MYB MYBL1

3.99e-06270231028361
Pubmed

Hematopoietic growth factor receptor genes as markers of lineage commitment during in vitro development of hematopoietic cells.

FLT3 CSF3R MYB

1.01e-05217038499630
Pubmed

AML1(-/-) embryos do not express certain hematopoiesis-related gene transcripts including those of the PU.1 gene.

FLT3 CSF3R MYB

1.17e-05227039811459
Pubmed

The temporal and spatial expression pattern of myosin Va, Vb and VI in the mouse ovary.

MYO5B MYO6

1.20e-05370216713372
Pubmed

NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report.

FLT3 NUP98

1.20e-05370225145343
Pubmed

Knock-in of a FLT3/ITD mutation cooperates with a NUP98-HOXD13 fusion to generate acute myeloid leukemia in a mouse model.

FLT3 NUP98

1.20e-05370222323452
Pubmed

Expression of insulin-like growth factor-binding protein 5 in neuroblastoma cells is regulated at the transcriptional level by c-Myb and B-Myb via direct and indirect mechanisms.

MYB MYBL2

1.20e-05370211973331
Pubmed

Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.

MYB MYBL2

1.20e-05370211423988
Pubmed

Acute myeloid leukemia with NUP98-HOXC13 fusion and FLT3 internal tandem duplication mutation: case report and literature review.

FLT3 NUP98

1.20e-05370219665070
Pubmed

C/EBPα and MYB regulate FLT3 expression in AML.

FLT3 MYB

1.20e-05370223340802
Pubmed

MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.

MYB MYBL1

1.20e-05370229149504
Pubmed

The granulocyte colony-stimulating factor receptor is required for the mobilization of murine hematopoietic progenitors into peripheral blood by cyclophosphamide or interleukin-8 but not flt-3 ligand.

FLT3 CSF3R

1.20e-0537029326216
Pubmed

Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction.

FLT3 NUP98

1.20e-05370224951466
Pubmed

NUP98::Nsd1 and FLT3-ITD collaborate to generate acute myeloid leukemia.

FLT3 NUP98

1.20e-05370237147424
Pubmed

Nucleolin, a novel partner for the Myb transcription factor family that regulates their activity.

MYB MYBL1

1.20e-05370210660576
Pubmed

Phospho-tyrosine dependent protein-protein interaction network.

PACRGL CSAD RABGAP1 WDFY3 ANKRD50 GAREM1 NAA16

1.90e-0541070725814554
Pubmed

High frequencies of simultaneous FLT3-ITD, WT1 and KIT mutations in hematological malignancies with NUP98-fusion genes.

FLT3 NUP98

2.39e-05470220861915
Pubmed

Soluble thrombopoietin receptor (Mpl) and granulocyte colony-stimulating factor receptor directly stimulate proliferation of primitive hematopoietic progenitors of mice in synergy with steel factor or the ligand for Flt3/Flk2.

FLT3 CSF3R

2.39e-0547028943846
Pubmed

The Flt3 receptor tyrosine kinase collaborates with NUP98-HOX fusions in acute myeloid leukemia.

FLT3 NUP98

2.39e-05470216861351
Pubmed

The ZNF75 zinc finger gene subfamily: isolation and mapping of the four members in humans and great apes.

ZNF75D ZNF75CP

2.39e-0547028661144
Pubmed

An evolutionarily conserved N-terminal acetyltransferase complex associated with neuronal development.

NAA15 NAA16

3.98e-05570212888564
Pubmed

A novel human NatA Nalpha-terminal acetyltransferase complex: hNaa16p-hNaa10p (hNat2-hArd1).

NAA15 NAA16

3.98e-05570219480662
Pubmed

Regulation of the Flt3 Gene in Haematopoietic Stem and Early Progenitor Cells.

FLT3 MYB

3.98e-05570226382271
Pubmed

Characterization of hARD2, a processed hARD1 gene duplicate, encoding a human protein N-alpha-acetyltransferase.

NAA15 NAA16

3.98e-05570216638120
Pubmed

Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination.

RNF14 KLK3

3.98e-05570219345326
Pubmed

Investigation of genetic susceptibility factors for human longevity - a targeted nonsynonymous SNP study.

GALNT14 FLT3 KL PIK3CG KLK3 TOP2A

4.09e-0531370620800603
Pubmed

Overexpression of myosin VI in prostate cancer cells enhances PSA and VEGF secretion, but has no effect on endocytosis.

MYO6 KLK3

5.96e-05670219855435
Pubmed

An important role for Myb-MuvB and its target gene KIF23 in a mouse model of lung adenocarcinoma.

MYB MYBL2

5.96e-05670227212033
Pubmed

Expression and characterization of c-Myb in prenatal odontogenesis.

MYB MYBL2

5.96e-05670221762405
Pubmed

Trip6 promotes dendritic morphogenesis through dephosphorylated GRIP1-dependent myosin VI and F-actin organization.

MYO5B MYO6

5.96e-05670225673849
Pubmed

PI3-Kinase-γ Has a Distinct and Essential Role in Lung-Specific Dendritic Cell Development.

FLT3 PIK3CG

8.33e-05770226453378
Pubmed

Specific and ubiquitous expression of different Zn finger protein genes in the mouse.

ZNF814 ZNF585B

8.33e-0577023143103
Pubmed

Mapping of unconventional myosins in mouse and human.

ZFP3 MYO5B MYO6

1.27e-04487038884266
Pubmed

Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor.

FLT3 MYB

1.42e-0497029159135
Pubmed

A B-Myb complex containing clathrin and filamin is required for mitotic spindle function.

MYB MYBL2

1.78e-041070218548008
Pubmed

p21 ras and phosphatidylinositol-3 kinase are required for survival of wild-type and NF1 mutant sensory neurons.

PIK3CG KLK3

2.17e-04117029852579
Pubmed

A synopsis of eukaryotic Nalpha-terminal acetyltransferases: nomenclature, subunits and substrates.

NAA15 NAA16

2.60e-041270219660095
Pubmed

A cochlear progenitor pool influences patterning of the mammalian sensory epithelium via MYBL2.

MYO6 MYBL2

2.60e-041270239254648
Pubmed

Trim33 Binds and Silences a Class of Young Endogenous Retroviruses in the Mouse Testis; a Novel Component of the Arms Race between Retrotransposons and the Host Genome.

KLK3 MYBL1

3.07e-041370226624618
Pubmed

Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence.

MYBL1 MYBL2

3.58e-041470217531812
Pubmed

A meta-analysis and genome-wide association study of platelet count and mean platelet volume in african americans.

PIK3CG MYB

3.58e-041470222423221
Pubmed

Chromosomal assignments of 17 structural genes and 11 related DNA fragments in rats (Rattus norvegicus) by Southern blot analysis of rat x mouse somatic cell hybrid clones.

KLK3 MYB

3.58e-04147021572638
Pubmed

Identification and overlapping expression of multiple unconventional myosin genes in vertebrate cell types.

MYO5B MYO6

3.58e-04147028022818
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

LMAN2L CSAD XXYLT1 NLRC5 WDFY3 SOWAHB ABCC10 GAREM1 MYBL2

3.65e-04110570935748872
Pubmed

A human MAP kinase interactome.

MYO6 SPTBN2 NUP98 NEB ZNF418 GAREM1

4.45e-0448670620936779
Pubmed

The ubiquitin E3 ligase ARIH1 regulates hnRNP E1 protein stability, EMT and breast cancer progression.

MYO6 CTTN TOP2A

4.57e-047470335102251
Pubmed

Dysplastic definitive hematopoiesis in AML1/EVI1 knock-in embryos.

CSF3R MYB

4.71e-041670215914564
Pubmed

Interaction of YAP with the Myb-MuvB (MMB) complex defines a transcriptional program to promote the proliferation of cardiomyocytes.

TOP2A MYBL2

4.71e-041670232469866
Pubmed

USP25 regulates Wnt signaling by controlling the stability of tankyrases.

FEM1B MYO6

4.71e-041670228619731
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

DMXL2 MYO5B MYO6 SPTBN2 LRRCC1 ZBTB26

4.79e-0449370615368895
Pubmed

Polymorphisms revealed by PCR with single, short-sized, arbitrary primers are reliable markers for mouse and rat gene mapping.

KLK3 MYB

5.33e-04177021617216
Pubmed

C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.

DMXL2 KIDINS220 ST7 RABGAP1 ANKRD50 VPS13B

5.38e-0450470634432599
Pubmed

Promyelocytic leukemia protein interacts with the apoptosis-associated speck-like protein to limit inflammasome activation.

NAA15 INPP4B

8.18e-042170224407287
Pubmed

Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac.

CSF3R MYB

8.99e-04227029324354
Pubmed

High-density polymorphisms analysis of 23 candidate genes for association with bone mineral density.

KL CSF3R

9.83e-042370220654748
Pubmed

Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

MYO6 SPTBN2 ZMYM3

1.23e-031047039205841
Pubmed

USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.

NEB CTTN TOP2A VPS13B

1.29e-0323470436243803
Pubmed

Human gingiva transcriptome during wound healing.

CSF3R CORIN CD163

1.33e-0310770328005267
Pubmed

Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.

NEB CTTN

1.46e-032870218067320
Pubmed

Integrating genetic and network analysis to characterize genes related to mouse weight.

KIDINS220 NEB

1.57e-032970216934000
Pubmed

Muscle developmental defects in heterogeneous nuclear Ribonucleoprotein A1 knockout mice.

MYO5B MYO6

1.67e-033070228077597
Pubmed

BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs.

NUP98 TOP2A

1.79e-033170223086144
Pubmed

A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells.

NUP98 CTTN TOP2A

1.90e-0312170322412018
Pubmed

Generation and annotation of the DNA sequences of human chromosomes 2 and 4.

PACRGL NAA15 LMAN2L WDFY3 MAP3K19

1.99e-0344270515815621
Cytoband13q12

FLT3 KL

6.19e-042470213q12
Cytoband11q13

SPTBN2 ROM1 CTTN

7.99e-0411870311q13
CytobandEnsembl 112 genes in cytogenetic band chr9q33

PHF19 ZBTB26 RABGAP1

1.26e-03138703chr9q33
Cytoband9q33.2

PHF19 ZBTB26

1.64e-03397029q33.2
CytobandEnsembl 112 genes in cytogenetic band chr4q31

NAA15 GATB INPP4B

2.06e-03164703chr4q31
GeneFamilyGATA zinc finger domain containing|Myb/SANT domain containing

MYB MYBL1 MYBL2

3.98e-0453493532
GeneFamilyN(alpha)-acetyltransferase subunits|GCN5 related N-acetyltransferases

NAA15 NAA16

4.67e-0412492660
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

RLF ZFP3 ZNF814 ZNF75D ZBTB26 ZNF418 ZNF587B ZNF585B

6.34e-0471849828
GeneFamilyAnkyrin repeat domain containing

FEM1B KIDINS220 ANKRD50 SOWAHB

4.14e-03242494403
ToppCellfacs-Liver-Non-hepatocytes-3m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PACRGL ZFP3 ATAD5 TOP2A INPP4B MYBL2

3.67e-0718069687347af8f28cf7c486c19f3f98c0afb022c323b5
ToppCell(61)_LYVE1_Macrophage|World / shred on Cell_type and subtype

DMXL2 NELL2 CSF3R WDFY3 KLK3 CD163

8.08e-07206696711e961a9a03bfd2f0958bd14f25f7f207a2f2b5
ToppCellLPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

GIPR DNAH3 EFHB MYB MAP3K19

3.77e-0615169581cf939ed4df9574fbfff265e109cb9f947d7e6e
ToppCellLPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

GIPR DNAH3 EFHB MYB MAP3K19

3.77e-061516959cbcbbc22965a9f0be8364e733d205dd64f2a533
ToppCellControl-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

GIPR DNAH3 EFHB MYB MAP3K19

4.15e-061546954e3bc24043144143842627cacf6f90dda2228910
ToppCellControl-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

GIPR DNAH3 EFHB MYB MAP3K19

4.15e-061546957556a4b2b062da5ae7ec2bbb66e745e7662db628
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PHF19 PIK3CG TOP2A MYBL1 MYBL2

6.90e-06171695c2dbc439af28d4fabb24d57685b75b2e588819b0
ToppCell10x5'-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue

DMXL2 CSF3R WDFY3 TOP2A CD163

7.31e-06173695783b8fa08b9d8f597f251793eae164151662f1f9
ToppCellkidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PHF19 ATAD5 TOP2A MYBL1 MYBL2

7.51e-06174695c26eac176e9b0cba385630fdc60e0314a4e4caac
ToppCell343B-Myeloid-Dendritic-cDC_proliferating_2|343B / Donor, Lineage, Cell class and subclass (all cells)

PHF19 ATAD5 TOP2A CD163 MYBL2

7.51e-06174695a75ba49ccea6bd3d78ada1092b46deb5202c58a5
ToppCelldroplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FLT3 PHF19 ATAD5 TOP2A MYBL2

7.72e-06175695a6913f992a1ea20b43e5adeca3ede3a6fda820ad
ToppCelldroplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PHF19 ATAD5 NLRC5 CD163 MYB

7.94e-061766951510cdfcfb46ce1196a1220c07fb5f3986c81b78
ToppCellLPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PHF19 ATAD5 TOP2A MYBL1 MYBL2

8.85e-06180695334e2b1f6eb7d4ece20b1c7b02107863f913237f
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ATAD5 TOP2A MYB MYBL1 MYBL2

8.85e-06180695f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df
ToppCell3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_Myeloid|bone_marrow / Manually curated celltypes from each tissue

GALNT14 TOP2A SOWAHB MYB MYBL2

9.34e-061826956745d464c3ff289726aa8164e9a43f407f8e4380
ToppCellHealthy-multiplets|Healthy / disease group, cell group and cell class

FLT3 ST7 LRRCC1 PLCD1 TOP2A

1.04e-051866952ec999b97e95afb898f8083042b0f188d3d234bc
ToppCell367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

PHF19 ATAD5 CORIN TOP2A MYBL2

1.09e-05188695f5102e8d95506c25c675094b86162a6a50087b64
ToppCellControl-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PHF19 ATAD5 TOP2A MYBL1 MYBL2

1.12e-051896951e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCellPBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

GALNT14 CSF3R ATAD5 TOP2A MYB

1.24e-05193695ccab6a0c76f574ef7e1d6d5f1e620376daf21bbf
ToppCellPBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

GALNT14 CSF3R ATAD5 TOP2A MYB

1.27e-0519469523318a1b55895b5166c6151f488a94a09b4627ff
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

DMXL2 FLT3 CSF3R WDFY3 CD163

1.30e-05195695580ed65b4152483b642a7e7dbdf00d03588c46f6
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

DMXL2 FLT3 CSF3R WDFY3 CD163

1.30e-05195695403d874198a7bde626b0d0b4efad8dbb34060761
ToppCellControl_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type

GIPR DNAH3 EFHB MYB MAP3K19

1.30e-0519569560067b5359174f0d1a8b5748bfc0690762e9e740
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

DMXL2 FLT3 CSF3R WDFY3 CD163

1.34e-05196695f943519bff51c3094776fd45889dadf9062c8379
ToppCell(6)_Macrophage|World / shred on Cell_type and subtype

DMXL2 NELL2 CSF3R WDFY3 CD163

1.37e-05197695010b275d4da4a896175ad7fbaa96d1dc11a0b744
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

DMXL2 FLT3 CSF3R WDFY3 CD163

1.37e-05197695ec46aa307ce5774b4c0fcba64514f2d0cab3c4f9
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DNAH3 MYO5B SPTBN2 CTTN MAP3K19

1.37e-051976955c4cee914baf7cb43e9cb99cc9e3ae823856dc15
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

DMXL2 FLT3 CSF3R WDFY3 CD163

1.37e-05197695b91016249b3585aa3536e96af18e4f1b1d2d5ce4
ToppCell3'_v3-lymph-node_spleen-Myeloid_Monocytic-Classical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue

DMXL2 FLT3 CSF3R WDFY3 CD163

1.40e-05198695187a04d498f0b355cb11c81172721698818082d6
ToppCellproximal-Hematologic-Proliferating_NK/T|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

PHF19 ATAD5 TOP2A MYBL1 MYBL2

1.40e-051986956c894fda309ec3d4bb446f63d5dde4e7f8c4fd89
ToppCellproximal-3-Hematologic-Proliferating_NK/T|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

PHF19 ATAD5 TOP2A MYBL1 MYBL2

1.40e-051986952777c5efe84ce3dbbe6175ecc1c987bc816ab74b
ToppCellproximal-Hematologic-Proliferating_NK/T-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

PHF19 ATAD5 TOP2A MYBL1 MYBL2

1.40e-051986952e121899f58a5024e26441bd326aac12c37fe6d1
ToppCell3'_v3-lymph-node_spleen-Myeloid_Monocytic|lymph-node_spleen / Manually curated celltypes from each tissue

DMXL2 FLT3 CSF3R WDFY3 CD163

1.40e-05198695065c8a9655d19f93dfdb453c78bbfe7d857caf3e
ToppCellmild-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

DMXL2 FLT3 CSF3R WDFY3 CD163

1.44e-05199695d0d286eafe935f9b3aaba5b783e8911251121b4a
ToppCellBronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CSF3R MYO5B MYO6 ST7 GAREM1

1.44e-051996955f7da3eab58ace6cddb3179a415cd839d5767958
ToppCellParenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CSF3R MYO5B MYO6 ST7 GAREM1

1.44e-051996955cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell10x5'-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue

PHF19 ATAD5 LRRCC1 TOP2A MYBL2

1.44e-05199695dee1cf8ee850a2bd57349418a9bcc0948fe9ac9e
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_ventral_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.

PHF19 ATAD5 TOP2A MYBL1 MYBL2

1.44e-05199695446cd7d960812519fe2b8e434578ef0b668c75ce
ToppCellLPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

GIPR DNAH3 EFHB MYB MAP3K19

1.47e-0520069596701a4d57753f5ec0dd5c7550054bbcc946bc5f
ToppCellControl_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type

PHF19 ATAD5 TOP2A MYBL1 MYBL2

1.47e-052006959bbc7b5561151f6ff65f40b3226271def732e5d9
ToppCellMS-IIF-Lymphocyte-T/NK-ILC|IIF / Disease, condition lineage and cell class

LRRCC1 ROM1 UCK1 NEB PGBD2

1.47e-05200695edb0b252e6ff9824908d1ff7d0d42710b00949c8
ToppCellSigmoid-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass

DMXL2 ATAD5 TOP2A CD163 MYBL2

1.47e-05200695372fe9018481a4e9ac6ab3af43705a48238c4376
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.

PHF19 ATAD5 TOP2A MYBL1 MYBL2

1.47e-05200695cea58274efbe7f9e3c3ef9fbb768ebfb917e21d9
ToppCellLPS-IL1RA-Endothelial-Epi-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

KL LMAN2L PKD1L3 MYBL1

3.19e-05116694cf4e3c34570f57502ec524881d351ef8e47976d2
ToppCellTransverse-Dendritic_cell-cDC1|Dendritic_cell / Region, Cell class and subclass

ST7 LRRCC1 NLRC5 PLCD1

8.90e-051516946870f3b5d2bfad849c3203658b5f28f0ae181295
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DNAH3 EFHB MYB MAP3K19

9.84e-051556945f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DNAH3 EFHB MYB MAP3K19

9.84e-051556940944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PHF19 TOP2A MYB MYBL2

1.01e-04156694955547dfeb1b1ad4957b4338701055726b22619f
ToppCelldroplet-Limb_Muscle-nan-24m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CSF3R TOP2A MYB MYBL2

1.09e-0415969439033d49501a4ecc00af6c256e7a569c903ad332
ToppCellSubstantia_nigra-Hematopoietic|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

CSF3R PIK3CG TOP2A CD163

1.11e-0416069419d71d02f06f34eff37d268a78e5eed34da4ca44
ToppCell390C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

RNF14 ATAD5 NLRC5 ZNF587B

1.14e-041616942fe77af3b41e6eacb707a64feea18f9991618173
ToppCellCOVID-CD8-memory_CD4|COVID / Condition, Cell_class and T cell subcluster

GIPR PACRGL PIK3CG ZNF587B

1.17e-0416269422b2a32217d357146c117e618813d451510a1801
ToppCell3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NEB PKD1L3 VPS13B MYBL1

1.19e-04163694e6213900f56257fe38ac7852351bea0340294be0
ToppCell3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NEB PKD1L3 VPS13B MYBL1

1.19e-04163694ed7319185c1ec384444309bb8be95691a0c2091c
ToppCellLPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PHF19 TOP2A MYBL1 MYBL2

1.19e-041636945285318c52aa31c9b22dc2ffff078e32e408604d
ToppCellsaliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

RNF14 NELL2 SPTBN2 ZNF75D

1.19e-04163694453e0bb292baca2938d24582fedfd6a8bb1e78e9
ToppCell390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

FLT3 TOP2A MYB MYBL2

1.19e-04163694aa5ea367f787c1543afb7eb80a801432e1c44011
ToppCell3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NEB PKD1L3 VPS13B MYBL1

1.19e-04163694ef35d7ff09aa364734fea7fdaab6260c0a3fbf09
ToppCell343B-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells)

DMXL2 ZFP3 CD163 MYB

1.22e-04164694d7053de88ef8e42cac6726a40e72f212659ee034
ToppCellwk_20-22-Hematologic-Myeloid-HSC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

FLT3 CSF3R SPTBN2 MYB

1.22e-04164694a35a0725b8bfe3cad5b85484217fd8a02bdee827
ToppCell367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

PHF19 ATAD5 TOP2A MYBL2

1.22e-04164694fb18b863152fb3109e2224c791c84c6371680a4e
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ATAD5 TOP2A MYBL1 MYBL2

1.25e-0416569488681101d7cf60b99b8ace5d8c0944323b937306
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TOP2A MYB MYBL1 MYBL2

1.28e-041666942642544070564debe2deb2938d2c33997bf5ef02
ToppCelldroplet-Limb_Muscle-nan-3m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SPTBN2 XXYLT1 TOP2A CD163

1.28e-0416669435db3022c33d6f8bb6587d9eec89a7cccb70271a
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TOP2A MYB MYBL1 MYBL2

1.31e-0416769450c29ea660bf07b890e4ac1a1985d0761d863dee
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PHF19 ATAD5 TOP2A MYBL2

1.31e-041676949280558baddea51aae47f3383d895a9b0c6749a4
ToppCell343B-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

ATAD5 TOP2A MYBL1 MYBL2

1.31e-041676943461d14e36f09ddc6ee5549ca4797e16d3f37fcc
ToppCellPND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PHF19 TOP2A INPP4B MYBL1

1.31e-04167694754e6412d3b9cc0b126e59593df2f5956b4712ef
ToppCelldroplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FPGS TOP2A ABCC10 MYBL2

1.31e-04167694bad33497ceeab968a7eb8a48b921c6f936390743
ToppCell5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Pro-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GALNT14 MYB MAP3K19 MYBL2

1.34e-04168694c833e3311af2582787d3ff2ad59d802fff865f8f
ToppCellwk_15-18-Hematologic-Myeloid-CMP|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

FLT3 CSF3R ZNF814 MYB

1.34e-041686949fc9c93ab7513bf4dfefc866b97c703208a238c9
ToppCelldroplet-Lung-nan-18m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT3 PHF19 TOP2A MYBL2

1.34e-0416869496f7411474edd673b8d3ee6b8a8bb185c246daaf
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ATAD5 TOP2A SOWAHB MYBL1

1.37e-04169694b253a4a50c06d36228fcd5d856c57202cbac158f
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ATAD5 TOP2A MYBL1 MYBL2

1.37e-041696940bc8ef341ce307b19018d4ac8de0a4d04254209d
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ATAD5 TOP2A MYBL1 MYBL2

1.37e-04169694e7514956b2e4298222ec443f98b2f5289451786e
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ATAD5 TOP2A MYBL1 MYBL2

1.37e-04169694e0607af8ae8609d43e26ff2a2cab92650bfcd5b7
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

PHF19 MYO5B TOP2A MYBL2

1.37e-04169694481e611b5fface58f1630f206c0b04fb54e24011
ToppCellfacs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PHF19 TOP2A INPP4B MYBL2

1.37e-04169694dbf9b1d52b29bf4b60bd23012cc1ea82d344747f
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_ventral_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.

FLT3 PHF19 TOP2A MYBL2

1.40e-0417069473601c873b177d5d134618d8e228c51381119f7d
ToppCellfacs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT3 ATAD5 GFER MYBL2

1.40e-041706944ab2a890c8631028ee9099d2faf6091c742a317b
ToppCell3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Pro-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ATAD5 NLRC5 MYB MYBL2

1.44e-0417169458bdcbc65062ac09f1c014e08302f938a3e6b252
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PHF19 TOP2A INPP4B MYBL2

1.44e-04171694b0373ed8283ee1792b6a490bff93906546978593
ToppCellfacs-Diaphragm-Limb_Muscle-18m-Myeloid-new-cluster|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT3 CSF3R TOP2A MYBL2

1.44e-04171694d0d92eb5152410c3b4dd4a3f1dc3cca0e18a85fd
ToppCell367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

ATAD5 PIK3CG TOP2A MYBL1

1.44e-04171694e3cab55f39879e2bd3e8bda91802181075839bc4
ToppCellMonocytes-IFN-activated_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

DMXL2 CSF3R KLK3 CD163

1.44e-04171694df1b631618839bee4a18a2ba9c730321e5015f36
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PHF19 TOP2A INPP4B MYBL2

1.44e-04171694b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

ATAD5 PIK3CG TOP2A MYBL1

1.44e-0417169452fdc2a4ec36fb91583b1215362548ceb6740ae1
ToppCell367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|367C / Donor, Lineage, Cell class and subclass (all cells)

PHF19 ATAD5 TOP2A MYBL2

1.47e-041726948d20eda599abf1e9e3e3b90f314acddee6a465a4
ToppCellMS-CD8-proli_CD4|MS / Condition, Cell_class and T cell subcluster

LMAN2L ZBTB26 ZNF587B MYBL1

1.47e-041726940b6dd257110b3f17fa71ab18a165b091a9d5ae9a
ToppCellPND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PHF19 ATAD5 TOP2A MYBL1

1.47e-041726942b6cd84c946b1e800caba452ae70145ea285fec1
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ATAD5 TOP2A CD163 MYBL2

1.47e-04172694ef33b5e0515c6d29fb6d9a673011c1b68ef264f3
ToppCelltumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass

LMAN2L MYO5B WDFY3 NEB

1.50e-0417369442c911ed16fabdabef063830e8407192d8bde950
ToppCellPND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CSF3R PHF19 TOP2A MYBL2

1.50e-0417369412c6875f881cb0fbff09d753b53c1cce7a95527f
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FLT3 TOP2A MYB MYBL2

1.50e-041736949f892d756d05e573af018db64edb130ff187ad47
ToppCellILEUM-non-inflamed-(3)_Inf._Macrophages|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

CSF3R PKD1L3 KLK3 CD163

1.50e-04173694a8db746992a915a8431ac5c155612e89c4af3cad
ToppCell10x5'-Lung-Myeloid_Dendritic-Cycling_Dendritic|Lung / Manually curated celltypes from each tissue

FLT3 ATAD5 ZNF814 TOP2A

1.50e-0417369462e0c18cfed9645e34a9d7029c94a8554f773714
ToppCelldroplet-Lung-nan-18m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT3 PHF19 TOP2A MYBL2

1.50e-0417369420a20429aa898097d5ec4880ed64846558b5890f
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ATAD5 TOP2A MYBL1 MYBL2

1.54e-0417469484da9faff088d05233183b425385beb054c92d1b
ToppCell10x5'-Liver-Lymphocytic_T_CD8-Tnaive/CM_CD8|Liver / Manually curated celltypes from each tissue

NELL2 KL ROM1 MYB

1.54e-0417469403918ca51ae3b4c9c1a74769b08ea23f518286ba
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PHF19 TOP2A MYBL1 MYBL2

1.54e-041746947b318796728001c17b4043d2b033330c7be40c78
DrugCinnarizine [298-57-7]; Down 200; 10.8uM; PC3; HT_HG-U133A

FEM1B GALNT14 DNAH3 KIDINS220 ST7 PLPBP WDFY3 CTTN

1.40e-071996885817_DN
DrugPhenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A

DNAH3 ATAD5 NUP98 TOP2A VPS13B ZMYM3

2.09e-051886866451_DN
DrugClindamycin hydrochloride [21462-39-5]; Up 200; 8.6uM; MCF7; HT_HG-U133A

MARCHF6 RABGAP1 PLCD1 WDFY3 NEB VPS13B

2.36e-051926862219_UP
DrugMonobenzone [103-16-2]; Down 200; 20uM; HL60; HT_HG-U133A

MYO6 CSAD MARCHF6 TOP2A ABCC10 INPP4B

2.36e-051926863054_DN
DrugPF-00539758-00 [351321-34-1]; Up 200; 10uM; PC3; HT_HG-U133A

FEM1B FPGS SPTBN2 PLCD1 CTTN GAREM1

2.43e-051936866421_UP
DrugPentetic acid [67-43-6]; Down 200; 10.2uM; HL60; HT_HG-U133A

DMXL2 KL ST7 NEB CTTN GAREM1

2.65e-051966863049_DN
DrugLovastatin [75330-75-5]; Down 200; 9.8uM; HL60; HT_HG-U133A

ATAD5 RABGAP1 PLCD1 NEB GAREM1 MYBL1

2.72e-051976862494_DN
DrugCarbimazole [22232-54-8]; Up 200; 21.4uM; HL60; HT_HG-U133A

ST7 SPTBN2 MARCHF6 NEB CTTN GFER

2.80e-051986862437_UP
Diseaseacute myeloid leukemia (implicated_via_orthology)

FLT3 NUP98 TOP2A MYBL2

1.19e-0812674DOID:9119 (implicated_via_orthology)
DiseaseB-lymphoblastic leukemia/lymphoma (is_marker_for)

FLT3 MYB

3.04e-054672DOID:0080630 (is_marker_for)
DiseasePleocytosis

FLT3 CSF3R

7.57e-056672C0151857
DiseaseLeukocytosis

FLT3 CSF3R

7.57e-056672C0023518
DiseaseAcute erythroleukemia - M6a subtype

FLT3 NUP98

1.41e-048672C2930975
DiseaseAcute myeloid leukemia FAB-M6

FLT3 NUP98

1.41e-048672C2930976
DiseaseAcute erythroleukemia - M6b subtype

FLT3 NUP98

1.41e-048672C2930977
DiseaseAcute erythroleukemia

FLT3 NUP98

1.41e-048672C2930974
Diseaseadult T-cell leukemia/lymphoma (is_marker_for)

CD163 MYB

1.81e-049672DOID:0050523 (is_marker_for)
Diseaseneutrophil percentage of leukocytes

FLT3 CSF3R ATAD5 NLRC5 TOP2A MYB PGBD2

4.64e-04610677EFO_0007990
DiseaseMalignant Glioma

TOP2A MYB MYBL1

5.49e-0470673C0555198
Diseasemixed gliomas

TOP2A MYB MYBL1

5.49e-0470673C0259783
DiseaseLeukemia, Myelocytic, Acute

FLT3 CSF3R NUP98 INPP4B

6.56e-04173674C0023467
DiseaseGlioma

TOP2A MYB MYBL1

1.03e-0387673C0017638
Diseasecardiovascular system disease (is_implicated_in)

UBR1 GIPR

1.04e-0321672DOID:1287 (is_implicated_in)
DiseaseAdenoid Cystic Carcinoma

TOP2A MYB MYBL1

1.55e-03100673C0010606
Diseaseopioid dependence

MYO6 SPTBN2 CORIN ANKRD50

2.09e-03237674EFO_0005611
Diseasebirth weight

KL PHF19 ATAD5 ZBTB26 RABGAP1

2.14e-03399675EFO_0004344

Protein segments in the cluster

PeptideGeneStartEntry
VHVQQKDDGCCLWHL

ATAD5

871

Q96QE3
NKEVQSEIRRGWHHC

GIPR

396

P48546
HKWAAVVGLEIHAQI

GATB

61

O75879
REWVFHKLQHCLQEK

ANKRD50

26

Q9ULJ7
WLEKEIAALHEICNH

DMXL2

2076

Q8TDJ6
VHKHLCIRNEWGTNQ

ASTN1

501

O14525
WQLLAGCHNNDHLVE

RABGAP1

576

Q9Y3P9
LHKDRALWQALKQCH

ABCC10

1346

Q5T3U5
HLEALCLFKAEHWNR

NUP98

1631

P52948
EHWNRCHKLIIRHLA

NUP98

1641

P52948
WAARKGHLECVKHLL

KIDINS220

176

Q9ULH0
VKHNGQIWVLENDRC

NELL2

646

Q99435
HWCNIHEALIRTEKG

ERVFC1-1

146

P60608
PHWDNLRKNVLTHCD

INPP4B

291

O15327
EQCIKLWLHALHLRQ

FEM1B

361

Q9UK73
KGLRNDVKSHVCWHV

NAA16

71

Q6N069
TLVHHWLGICQEQFD

GAREM1

321

Q9H706
HQECLVQWLKHSRKE

MARCHF6

36

O60337
LRDWELQVHFKIHGQ

LMAN2L

106

Q9H0V9
IGKQCRERWHNHLNP

MYB

126

P10242
RGLRNDLKSHVCWHV

NAA15

71

Q9BXJ9
TLAHRLCQKWAEGHL

NLRC5

236

Q86WI3
DQRQKLQHWIHSCLR

PLCD1

136

P51178
LQHWIHSCLRKADKN

PLCD1

141

P51178
HCEVNRDWLQPLLHR

GALNT14

201

Q96FL9
EPLWIRCKAVHVNHG

FLT3

266

P36888
WDVIQKHCLEAHQTL

DNAH3

386

Q8TD57
KHCLEAHQTLLNKWI

DNAH3

391

Q8TD57
THLQDVEKCIRLWIH

DNAH3

2291

Q8TD57
HHVCADGWQEILSQL

CORIN

711

Q9Y5Q5
DVCQRHGLWLHVDAA

CSAD

261

Q9Y600
WQPGLHINQKCELRH

CSF3R

256

Q99062
VWNLASKKHHRGEVC

EFHB

796

Q8N7U6
DQVLLRCLEHQQHWN

FPGS

461

Q05932
RLCFQELGHHVKLWI

KL

671

Q9UEF7
QLGSDVQLLAWIKHH

FAM172BP

271

A6NC97
HWDIEDAHVLCQQLK

CD163

611

Q86VB7
NHHRQCLEKEENWKS

MAP3K19

296

Q56UN5
IGKQCRERWHNHLNP

MYBL1

121

P10243
CRLVHGSVKHRLQWE

PACRGL

91

Q8N7B6
GRVKHIVHQAFWDVL

TCP11L2

101

Q8N4U5
RLGKQCRERWHNHLN

MYBL2

116

P10244
CRERWHNHLNPEVKK

MYBL2

121

P10244
ICEAHKVLGNRWAEI

MYBL2

146

P10244
CHVQRGFLAHIWNKE

PKD1L3

51

Q7Z443
HWKRVEGALNLLHCT

ST7

451

Q9NRC1
CPEIKWHFIGHLQKQ

PLPBP

86

O94903
HWIAKHGDLRALQDL

SOWAHB

636

A6NEL2
FTQWLCHLHNEVNRK

GFER

166

P55789
GHWIIHQDKRTRCAL

PGBD2

551

Q6P3X8
QWVRHCLKNGEEIHV

PIK3CG

291

P48736
LCKHLDNLWEEHRGS

RNF14

106

Q9UBS8
HIQDILNGDICKWHR

UCK1

226

Q9HA47
EEAALKCWQNHLAHE

WDFY3

2241

Q8IZQ1
DWKTLKRHCHQLLGQ

RLF

471

Q13129
QHFLQDCHELKLWID

SPTBN2

1281

O15020
QNLWAQGCHEVLLEH

ROM1

246

Q03395
CALGWDHQEKLQLHE

CTTN

246

Q14247
QKLCHQWLRPEIHSK

ZNF75CP

71

Q92670
RKLHLVWQQHCIIEE

UBR1

1716

Q8IWV7
CPGEKLWDHNQHRKI

ZNF585B

96

Q52M93
LAFVNHHWELLQLGK

PHF19

286

Q5T6S3
LKVIHEQVNHRWEVC

TOP2A

286

P11388
QGTHHKQKLHRCEAW

ZNF587B

111

E7ETH6
QKLCHQWLRPEIHSK

ZNF75D

71

P51815
QGTHHKQKLHRCEAW

ZNF418

101

Q8TF45
FWGQEHLNCLVLLHE

VPS13B

2246

Q7Z7G8
HACKRQGKLLETIHW

ZMYM3

721

Q14202
NIRGVDKGLQWHHQC

ZBTB26

261

Q9HCK0
QGTHHKQKLHRCEAW

ZNF814

111

B7Z6K7
HPKLFHVLDCTWNRQ

XXYLT1

341

Q8NBI6
WDNSELLLHQKIHIG

ZFP3

431

Q96NJ6
HPQWVLTAAHCIRNK

KLK3

56

P07288
KWHDKGELLCHLETQ

LRRCC1

906

Q9C099
QLFGWIVEHINKALH

MYO5B

411

Q9ULV0
HLAELVKRVNHWLTC

MYO6

776

Q9UM54
RLHEWICHPDLQVND

NEB

4816

P20929